Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
COMBINATION THERAPY USING LIPOSOMAL IRINOTECAN AND A PARP INHIBITOR FOR CANCER TREATMENT
No-Receipt date
2021-00704 - 22/02/2021
No-Filing date
20210400477 - 22/02/2021
No-Granting date
3106391 - 01/03/2021
No-EPO application date
16757498.7 - 19/08/2016
No-EPO granting date
3337467 - 09/12/2020
Gazette No-Publication date of application
-
Gazette No-Publication date of granted patent
3/2021 - 16/04/2021
Expiration date
20/08/2036
Kind of title
Validation of European Patent
Legal status
NOT VALID
Priorities
US201562207709 P20/08/2015/US
US201562207760 P20/08/2015/US
US201562269756 P18/12/2015/US
US201562269511 P18/12/2015/US
US201662308924 P16/03/2016/US
US201662323422 P15/04/2016/US
Active Substance of Supplementary Certificates
-
IPC Classification
Ipc Class
A61P 35/00
A61K 9/127
A61K 47/06
A61K 31/55
A61K 31/502
A61K 31/475
A61K 31/4745
A61K 31/436
A61K 31/4184
A61K 31/416
A61K 31/166
A61K 31/04
Related Documents
Related Titles
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
1271876
IPSEN BIOPHARM LTD.
ASH ROAD
WREXHAM INDUSTRIAL ESTATE WREXHAM LL13 9UF
UNITED KINGDOM (GREAT BRITAIN)
Inventors
Code
Firstname
Surname
3249833
BLANCHETTE, SARAH, F.
3249834
DRUMMOND, DARYL, C.
3249835
FITZGERALD, JONATHAN, BASIL
3249836
MOYO, VICTOR
Representatives
Code
Firstname
Surname
Address
Town
Zip
3190
KONSTANTINOS
KILIMIRIS "PATRINOS & KILIMIRIS DIKIGORIKI ETAIRIA"
CHATZIGIANNI MEXI 7
ATHINA (ATTIKIS)
11528
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
8149
KONSTANTINOS
KILIMIRIS
CHATZIGIANNI MEXI 7
ATHINA (ATTIKIS)
11528
GREECE
Owners History
Title Instruments
Payments history
7 renewals have been done
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).